PATENT CLAIM ANALYSIS

Application Number: 16374701
Application Type: Utility
Filing Date: 2019-04
Publication Date: 2019-07
Patent Classification: ["514", "001100"]

Abstract:
By employing a pharmacodynamic dosing regimen, the effectiveness of a protocol for treatment of a proteinuric kidney disease with voclosporin can be maximized while minimizing undesirable side effects.

Claim (Index 21):
The method of  claim 17  or  18  wherein said predetermined daily dosage is 39.5 mg voclosporin BID or 31.6 mg voclosporin BID or 23.7 mg voclosporin BID or 15.8 mg voclosporin BID or 7.9 mg voclosporin BID.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 100.0
- Lexical Diversity: 1.11111
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15835219', '13737535', '16208172', '16335662', '15918401']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7300752195663017
- 35 USC 102 Novelty (BERT): 0.5788314959366994
- Combined Prediction Score: 0.7149508472033415
- Mean Citation Score: 235.234764
- Max Citation Score: 494.36295
- Similarity Product: 389.5032794998616

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test